Table V.
Correlation between E-cadherin expression and clinicopathological parameters in epithelial ovarian cancer.
| E-cadherin expression | ||||||
|---|---|---|---|---|---|---|
| Clinicopathological parameters | Total number of cases (n) | Negative | Positive | Positive rate (%) | χ2 value | P-value |
| Age (years) | ||||||
| <53 | 154 | 106 | 48 | 31.2 | 0.105 | 0.746 |
| ≥53 | 146 | 103 | 43 | 29.5 | ||
| Pathological type | ||||||
| Serous carcinoma | 168 | 116 | 52 | 31.0 | 0.139 | 0.987 |
| Mucinous carcinoma | 63 | 44 | 19 | 30.2 | ||
| Endometrial carcinoma | 54 | 38 | 16 | 29.6 | ||
| Clear cell carcinoma | 15 | 11 | 4 | 26.7 | ||
| FIGO staging | ||||||
| I–II | 143 | 63 | 80 | 55.9 | 84.812 | <0.001 |
| III–IV | 157 | 146 | 11 | 7.0 | ||
| Pathological staging | ||||||
| G1+G2 | 124 | 50 | 74 | 59.7 | 86.124 | <0.001 |
| G3 | 176 | 159 | 17 | 9.7 | ||
| Lymph node metastasis | ||||||
| Yes | 186 | 158 | 28 | 15.1 | 54.076 | <0.001 |
| No | 114 | 51 | 63 | 55.3 | ||